Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Alternatively activated macrophages (AAMs) (or M2a) can inhibit colitis but may also be associated with fibrosis. Thus, by using the dinitrobenzene sulfonic (DNBS) murine model of colitis, this study aimed to determine whether 1) bone marrow (BM)-derived AAMs could reduce colitis, 2) any anticolitic effect of BM-AAMs was IL-10 dependent, and 3) repeated AAM treatments remained effective and were associated with fibrosis in the gut or other tissues. Balb/c mice received AAMs (10 6 intraperitoneally) from wild-type (WT) or IL-10−/− mice 48 h prior to DNBS (3 mg intrarectally) with disease assessed 72 h later, or they received three doses of DNBS at 2-wk intervals ± AAMs 6 h post-DNBS to mimic a treatment regimen. DNBS-treated mice developed colitis; this was significantly less severe in mice receiving WT AAMs and less so in animals given IL-10−/− AAMs, indicating a role for IL-10 in the inhibition of DNBS-driven colitis. Similarly, after the third AAM treatment lesser colonic histopathology was observed compared with time-matched DNBS-only-treated animals, and notably there was no evidence of increased fibroses in the colon, terminal ileum, lung, or liver of AAM-treated mice as assessed by quantitative PCR for prolyl-4-hydrolase, α-smooth muscle actin, and collagen (type IIIα) and histochemical and biochemical assessment of collagen deposition. This study provides mechanistic insight to the anticolitic capacity of AAMs and indicates that repeated adoptive transfer of ex vivo programmed BM-AAMs is safe and efficacious in the treatment of DNBS-induced murine colitis, providing additional support for their consideration as an immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541 · cited 1×
“However, Arg1 metabolizes L-arginine to produce proline and ornithine, which promote collagen production and cell division; although these events would promote tissue restitution after injury, an overactive response could result in tissue remodeling, fibrosis, and stricturing (44).”
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“With respect to helminth infections, the characteristic increase in IL-4 and IL-13 will give rise to an AAM, and although only a small amount of data is available on the role of the AAM following infection with helminth parasites (2), the IL-4 IL-13 educated murine AAM has been ascribed anti-inflammatory and proresolu…”
Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130
Arginase-1–Expressing Macrophages Suppress Th2 Cytokine–Driven Inflammation and Fibrosis
Pesce, J. T., Ramalingam, T. R., Mentink-Kane, M. M., Wilson, M. S., El Kasmi, K. C., Smith, A. M., Thompson, R. W., Cheever, A. W., Murray, P. J., & Wynn, T. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000371 · Cited by 816 · cited 1×
“Data have been presented in favor of AAMs being profibrotic (27, 31, 33, 46), whereas others report that macrophages/ arginase-1 can protect against liver fibrosis induced by infection with the helminth parasite Schistosoma mansoni (26) or with carbon tetrachloride (36).”
Duijvestein, M., Vos, A. C. W., Roelofs, H., Wildenberg, M. E., Wendrich, B. B., Verspaget, H. W., Kooy-Winkelaar, E. M. C., Koning, F., Zwaginga, J. J., Fidder, H. H., et al. (2010) · Gut · doi:10.1136/gut.2010.215152 · Cited by 622 · cited 1×
“These studies, along with those involving mesenchymal stromal cells (6, 8) or dendritic cells (12) and other type 2 macrophages, support the case for autologous cell immunotherapy for IBD and potentially other inflammatory diseases (40, 41).”
Anthony, R. M., Urban, J. F., Alem, F., Hamed, H. A., Rozo, C. T., Boucher, J.-L., Van Rooijen, N., & Gause, W. C. (2006) · Nature Medicine · doi:10.1038/nm1451 · Cited by 522 · cited 2×
“Subclasses of AAMs have also been found to be protective and possess proresolution properties in other models of disease, such as nematode infection (2), renal disease (40), experimental allergic encephalitis as a model of multiple sclerosis (37), and spinal cord injuries (19).”
A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1518oc · Cited by 497
Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis
Gibbons, M. A., MacKinnon, A. C., Ramachandran, P., Dhaliwal, K., Duffin, R., Phythian-Adams, A. T., van Rooijen, N., Haslett, C., Howie, S. E., Simpson, A. J., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1719oc · Cited by 466 · cited 1×
“In respect to AAMs, their anticolitic mechanism of action is unclear, their utility as a repeated therapy is unknown (an important consideration in relapsing-remitting disorders such as IBD), and the possibility that they drive fibrosis could be a concern (11, 25).”
Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
Weber, M. S., Prod'homme, T., Youssef, S., Dunn, S. E., Rundle, C. D., Lee, L., Patarroyo, J. C., Stüve, O., Sobel, R. A., Steinman, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1620 · Cited by 447 · cited 1×
“These studies, along with those involving mesenchymal stromal cells (6, 8) or dendritic cells (12) and other type 2 macrophages, support the case for autologous cell immunotherapy for IBD and potentially other inflammatory diseases (40, 41).”
Song, E., Ouyang, N., Hörbelt, M., Antus, B., Wang, M., & Exton, M. S. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1687 · Cited by 447
Thomas, J. A., Pope, C., Wojtacha, D., Robson, A. J., Gordon-Walker, T. T., Hartland, S., Ramachandran, P., Van Deemter, M., Hume, D. A., Iredale, J. P., et al. (2011) · Hepatology · doi:10.1002/hep.24315 · Cited by 346 · cited 1×
“Data have been presented in favor of AAMs being profibrotic (27, 31, 33, 46), whereas others report that macrophages/ arginase-1 can protect against liver fibrosis induced by infection with the helminth parasite Schistosoma mansoni (26) or with carbon tetrachloride (36).”
Weng, M., Huntley, D., Huang, I.-F., Foye-Jackson, O., Wang, L., Sarkissian, A., Zhou, Q., Walker, W. A., Cherayil, B. J., & Shi, H. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4721 · Cited by 116 · cited 1×
“Fibrosis is not the only potential concern with AAMs: for instance, AAM-type cells have been implicated in worsening of Citrobacter rodentium-induced colitis in mice (43), cerebral cryptococcosis (34), and Whipple’s disease (7).”
Cited by
Morrison, T. J., Jackson, M. V., Cunningham, E. K., Kissenpfennig, A., McAuley, D. F., O’Kane, C. M., & Krasnodembskaya, A. D. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0170oc · Cited by 796
Mack, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.11.010 · Cited by 514
Liang, L., Liu, L., Zhou, W., Yang, C., Mai, G., Li, H., & Chen, Y. (2022) · Clinical Science · doi:10.1042/cs20210778 · Cited by 291
Ziegler, T., Rausch, S., Steinfelder, S., Klotz, C., Hepworth, M. R., Kühl, A. A., Burda, P.-C., Lucius, R., & Hartmann, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401217 · Cited by 85
Metadata
- Authors
- Leung, G., Wang, A., Fernando, M., Phan, V. C., & McKay, D. M.
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2013-05-01
- Volume
- 304
- Issue
- 9
- Pages
- G781-G792
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- OpenAlex
- W1999315698
- Cited by
- 57
- References
- 12
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.